Gut microbiota-based metabolites of Xiaoyao Pills (a typical Traditional Chinese medicine) ameliorate depression by inhibiting fatty acid amide hydrolase levels in brain.
暂无分享,去创建一个
H. Zhang | Zheng-Wei Zhang | Hang Yu | Jie Fu | Pei Han | Yan Wang | Jian Jiang | Hui Xu | Xin Yang | Mengsen Bu | Jiahui Hu | Jin Lu
[1] M. Papp,et al. Models of Affective Illness: Chronic Mild Stress in the Rat , 2023, Current protocols.
[2] Y. Lou,et al. The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends , 2022, Frontiers in Cellular and Infection Microbiology.
[3] H. Hosseinzadeh,et al. The effects of ginger and its constituents in the prevention of metabolic syndrome: A review , 2022, Iranian journal of basic medical sciences.
[4] Zhaopeng Yang,et al. Development of the Chinese Pharmacopoeia 2020 Edition General Chapters: A Review , 2021 .
[5] Xuetao Cao,et al. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota , 2021, Signal Transduction and Targeted Therapy.
[6] N. Kolla,et al. Elevated Brain Fatty Acid Amide Hydrolase Induces Depressive-Like Phenotypes in Rodent Models: A Review , 2021, International journal of molecular sciences.
[7] A. Ornoy,et al. Animal Models of Depression: What Can They Teach Us about the Human Disease? , 2021, Diagnostics.
[8] A. Shikov,et al. Medicinal Plants from the 14th edition of the Russian Pharmacopoeia, recent updates. , 2020, Journal of ethnopharmacology.
[9] H. Wagner,et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases , 2020, Medicinal research reviews.
[10] C. Tzeng,et al. Role of gut microbiota in identification of novel TCM-derived active metabolites , 2020, Protein & Cell.
[11] S. Im,et al. Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics , 2020, Experimental & molecular medicine.
[12] K. Ning,et al. Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare , 2020, Frontiers in Pharmacology.
[13] G. de Fabritiis,et al. The endocannabinoid hydrolase FAAH is an allosteric enzyme , 2020, Scientific Reports.
[14] Cheng Lu,et al. Gut microbiota as an "invisible organ" that modulates the function of drugs. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[15] R. Tripathi. A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents. , 2019, European journal of medicinal chemistry.
[16] Lei Zhang,et al. Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior , 2019, Cell.
[17] Wei-Jia Kong,et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia , 2019, Acta pharmaceutica Sinica. B.
[18] K. Blennow,et al. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer’s Disease biomarker discovery cohort , 2019, Alzheimer's & Dementia.
[19] Jian-Dong Jiang,et al. Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin , 2019, Front. Pharmacol..
[20] Lanjuan Li,et al. Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese Medicine , 2019, Engineering.
[21] L. Lao,et al. Emerging Applications of Metabolomics in Traditional Chinese Medicine Treating Hypertension: Biomarkers, Pathways and More , 2019, Front. Pharmacol..
[22] C. Legido-Quigley,et al. Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson’s Disease , 2019, Metabolites.
[23] Jian-Dong Jiang,et al. Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin , 2018, Theranostics.
[24] T. Hofmann,et al. Saponins from European Licorice Roots ( Glycyrrhiza glabra). , 2018, Journal of natural products.
[25] P. Xie,et al. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents , 2018, Molecular Psychiatry.
[26] Menglin Jiang,et al. Efficacy and Safety of Xiaoyao Formula as an Adjuvant Treatment for Post‐Stroke Depression: A Meta‐Analysis , 2018, Explore.
[27] T. Nishikawa,et al. Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity. , 2018, Journal of affective disorders.
[28] Floor Hugenholtz,et al. Mouse models for human intestinal microbiota research: a critical evaluation , 2017, Cellular and Molecular Life Sciences.
[29] S. Banni,et al. Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications , 2017, Front. Physiol..
[30] Wei-Jia Kong,et al. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. , 2017, Metabolism: clinical and experimental.
[31] B. Stecher,et al. The mouse gut microbiome revisited: From complex diversity to model ecosystems. , 2016, International journal of medical microbiology : IJMM.
[32] C. Legido-Quigley,et al. Assessment of Polygonum capitatum Buch.-Ham. ex D.Don by metabolomics based on gas chromatography with mass spectrometry. , 2016, Journal of separation science.
[33] D. Marazziti,et al. Depression, Serotonin and Tryptophan. , 2016, Current pharmaceutical design.
[34] Guowang Xu,et al. Serum metabolomics study of Traditional Chinese medicine formula intervention to polycystic ovary syndrome. , 2016, Journal of pharmaceutical and biomedical analysis.
[35] C. Bernstein,et al. Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota , 2015, PloS one.
[36] A. Ericsson,et al. Manipulating the Gut Microbiota: Methods and Challenges. , 2015, ILAR journal.
[37] Xi Chen,et al. Transforming berberine into its intestine-absorbable form by the gut microbiota , 2015, Scientific Reports.
[38] S. Givan,et al. Effects of Vendor and Genetic Background on the Composition of the Fecal Microbiota of Inbred Mice , 2015, PloS one.
[39] Xi-jun Wang,et al. The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine , 2015, Phytotherapy research : PTR.
[40] Guowang Xu,et al. Metabolomics and traditional Chinese medicine , 2014 .
[41] S. Dowd,et al. Functional divergence in gastrointestinal microbiota in physically-separated genetically identical mice , 2014, Scientific Reports.
[42] Yu Fan,et al. Meta-analysis of Chinese herbal Xiaoyao formula as an adjuvant treatment in relieving depression in Chinese patients. , 2014, Complementary therapies in medicine.
[43] Robert C. Edgar,et al. UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.
[44] N. Tam,et al. Illumina Sequencing of 16S rRNA Tag Revealed Spatial Variations of Bacterial Communities in a Mangrove Wetland , 2013, Microbial Ecology.
[45] I. Mizrahi,et al. Exploring the bovine rumen bacterial community from birth to adulthood , 2013, The ISME Journal.
[46] Qingqiu Mao,et al. The antidepressant-like effects of paeoniflorin in mouse models , 2013, Experimental and therapeutic medicine.
[47] D. Kaufer,et al. Blood–brain barrier dysfunction–induced inflammatory signaling in brain pathology and epileptogenesis , 2012, Epilepsia.
[48] N. Tam,et al. Comparison of the Levels of Bacterial Diversity in Freshwater, Intertidal Wetland, and Marine Sediments by Using Millions of Illumina Tags , 2012, Applied and Environmental Microbiology.
[49] Y. Kase,et al. The Blood–Brain Barrier Permeability of 18β-Glycyrrhetinic Acid, a Major Metabolite of Glycyrrhizin in Glycyrrhiza Root, a Constituent of the Traditional Japanese Medicine Yokukansan , 2012, Cellular and Molecular Neurobiology.
[50] Adem Can,et al. The mouse forced swim test. , 2011, Journal of visualized experiments : JoVE.
[51] Zhang-Jin Zhang,et al. Meta-analysis of randomized controlled trials to assess the effectiveness and safety of Free and Easy Wanderer Plus, a polyherbal preparation for depressive disorders. , 2011, Journal of psychiatric research.
[52] Ruth Ley,et al. Unravelling the effects of the environment and host genotype on the gut microbiome , 2011, Nature Reviews Microbiology.
[53] James R. Cole,et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis , 2008, Nucleic Acids Res..
[54] Y James Kang,et al. Herbogenomics: From Traditional Chinese Medicine to Novel Therapeutics , 2008, Experimental biology and medicine.
[55] A. Schousboe,et al. The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer , 2006, Journal of neurochemistry.
[56] T. Cassano,et al. Correction for Gobbi et al., Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Patil,et al. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons , 2005, Neuroscience Letters.
[58] B. Cravatt,et al. Structure and function of fatty acid amide hydrolase. , 2005, Annual review of biochemistry.
[59] P. Lipton,et al. Ischemic cell death in brain neurons. , 1999, Physiological reviews.
[60] E. Syvälahti. Biological aspects of depression , 1994, Acta psychiatrica Scandinavica. Supplementum.
[61] G. Everett,et al. L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of Mice , 1970, Science.
[62] S. Udenfriend,et al. TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.
[63] V. Rajeswari,et al. Preservatives in Beverages: Perception and Needs , 2019, Preservatives and Preservation Approaches in Beverages.
[64] J. Bains,et al. Neurobiological Interactions Between Stress and the Endocannabinoid System , 2016, Neuropsychopharmacology.
[65] O. Fiehn. Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.